PMID: 8611394Apr 1, 1996Paper

A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells

British Journal of Cancer
L HomolyaB Sarkadi

Abstract

A rapid, functional and quantitative diagnostic method for the estimation of the P-glycoprotein (P-gp)-dependent multidrug resistance is required in the clinical treatment of human tumours, as chemotherapy protocols and resistance-reversing agents could be applied accordingly. In the present work, by using a calcein accumulation method in combination with immunorecognition and drug-resistance studies, a new method is described for the quantitative estimation of the expression and function of the multidrug transporter. MDR1-transfected and drug-selected tumour cell lines with various levels of drug resistance were examined. The expression of P-gp and its cell-surface appearance were assessed by quantitative immunoblotting and by immunofluorescence cytometry. The transport function of the P-gp was assessed by measuring the extrusion of calcein acetoxymethyl ester (AM) with fluorometry and flow cytometry, while in parallel experiments drug resistance was directly examined in cell survival assays. The MDR1 activity factor (MAF), calculated from the calcein AM extrusion assay, is demonstrated to provide a reliable quantitative measure for MDR1 specific activity, reflecting cellular drug resistance. This relatively simple and rapid n...Continue Reading

Citations

Aug 3, 2002·Leukemia & Lymphoma·János KappelmayerKatalin Jakab
Feb 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Szilárd TóthAhcène Boumendjel
May 24, 1996·The Journal of Biological Chemistry· Bakos EB Sarkadi
Oct 27, 2004·Histochemistry and Cell Biology·Jacopo UggeriGuido Orlandini
Nov 9, 2010·Journal of Biomolecular Screening·Péter SzerémyKrisztina Herédi-Szabó
Feb 26, 2008·Biochemistry. Biokhimii︠a︡·T P StromskayaA A Stavrovskaya
Oct 20, 2004·British Journal of Pharmacology·James I ElliottChristopher F Higgins
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Hristos GlavinasPéter Krajcsi
Jul 31, 2009·Journal of Biomechanical Engineering·Ka Yaw Teo, Bumsoo Han
Aug 27, 2014·Molecular Reproduction and Development·Tufan GökirmakAmro Hamdoun
Feb 11, 2014·Current Protocols in Toxicology·Kristin M BircsakLauren M Aleksunes
Sep 8, 2016·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Zsuzsanna NeradaÁgnes Telbisz
Jun 30, 2019·Cellular and Molecular Life Sciences : CMLS·Boglárka ZámbóBalázs Sarkadi
Jan 15, 1999·Pathology Oncology Research : POR·G SzakácsB Sarkadi
Jul 17, 1999·The American Journal of Physiology·S ItoG Koren
May 17, 2006·Cancer Chemotherapy and Pharmacology·Christine MüllerArmin Buschauer
Sep 2, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Oliver von RichterKarl Zech
Sep 10, 2005·Expert Review of Molecular Diagnostics·Marion M Schuierer, Thomas Langmann
Nov 26, 1999·Biochemical Pharmacology·A F CastroG A Altenberg
Jul 12, 2002·Biochemical Pharmacology·Loukas TatidisSigurd Vitols
Aug 25, 2004·Cancer Cell·Gergely SzakácsMichael M Gottesman
Jul 4, 2002·Hematology/oncology Clinics of North America·Roger S RileyGina Romagnoli
Mar 3, 2007·Biochemical Pharmacology·Caroline Henrike StorchJohanna Weiss
Jul 31, 2007·Biochimica Et Biophysica Acta·Agnes TelbiszBalázs Sarkadi
Jan 10, 2008·Biochemical and Biophysical Research Communications·Tamás I OrbánLászló Homolya
Mar 20, 2010·Biochemical Pharmacology·Gauri PatwardhanYong-Yu Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.